0001209191-21-021581.txt : 20210317 0001209191-21-021581.hdr.sgml : 20210317 20210317200034 ACCESSION NUMBER: 0001209191-21-021581 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210316 FILED AS OF DATE: 20210317 DATE AS OF CHANGE: 20210317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: James Steven P CENTRAL INDEX KEY: 0001243025 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38582 FILM NUMBER: 21752511 MAIL ADDRESS: STREET 1: C/O OCERA THERAPUETICS STREET 2: 525 UNIVERSITY AVENUE, SUITE 610 CITY: PALO ALTO STATE: CA ZIP: 94301 FORMER NAME: FORMER CONFORMED NAME: JAMES STEVEN P DATE OF NAME CHANGE: 20030617 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allakos Inc. CENTRAL INDEX KEY: 0001564824 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454798831 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 975 ISLAND DRIVE STREET 2: SUITE 201 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-597-5002 MAIL ADDRESS: STREET 1: 975 ISLAND DRIVE STREET 2: SUITE 201 CITY: REDWOOD CITY STATE: CA ZIP: 94065 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-16 0 0001564824 Allakos Inc. ALLK 0001243025 James Steven P C/O ALLAKOS INC. 975 ISLAND DRIVE, SUITE 201 REDWOOD CITY CA 94065 1 0 0 0 Common Stock 2021-03-16 4 S 0 3500 121.65 D 0 D Common Stock 2021-03-16 4 M 0 3500 0.525 A 3500 D Stock Option (Right to buy) 0.525 2021-03-16 4 M 0 3500 0.00 D 2026-04-28 Common Stock 3500 59380 D This transaction was executed in multiple trades at prices ranging from $121.50 to $121.70 per share. The sale price reported represents the weighted average sale price . Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price. On April 28, 2016, the Reporting Person was granted an option to purchase 62,880 ordinary shares pursuant to the Company's 2012 Equity Incentive Plan. The option vests as to one forty-eight of the shares on May 28, 2016 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. /s/ Jeff Macfarland, by power of attorney 2021-03-17